Wockhardt Hints at More Buys (India)
This article was originally published in PharmAsia News
Executive Summary
Wockhardt Chairman Habil Khorakiwala says the India-based pharmaceutical and biotechnology company is hungry for more acquisitions as part of its goal to generate $1 billion in global sales by 2009. Wockhardt is restructuring its European operations in consultation with Bain & Company after it purchased Negma Laboratories of France in May 2007 for $265 million. Negma is France's fourth largest pharmaceutical company. Wockhardt has been targeting Europe for acquisitions; to date it has acquired Britain-based Wallis, Britain-based CP Pharmaceuticals, Germany-based Esparma, and Ireland-based Pinewood Laboratories. (Click here for more